Analyzing Tumor Metabolism In Vivo
- 6 March 2017
- journal article
- Published by Annual Reviews in Annual Review of Cancer Biology
- Vol. 1 (1) , 99-117
Abstract
Altered metabolism is a clinically actionable hallmark of cancer. Some reprogrammed activities in cancer cells have predictive value and others are associated with therapeutic liabilities. Recent years have brought increased exploration of metabolism in intact tumors, complementing a large literature on cancer cell lines. We review the expanding tool kit available for studying the metabolic features of tumors in vivo. These techniques include metabolomics, positron emission tomography, magnetic resonance spectroscopy, and multiparametric magnetic resonance imaging, and they vary according to their invasiveness and breadth of metabolic assessment. Special attention is given to the emerging role of intraoperative infusions of stable, isotope-labeled nutrients, which have provided the first view of true metabolic flux in human tumors. These studies also demonstrate markedly different metabolic phenotypes from those observed in culture, indicating the potential for this approach to provide a disease-relevant view of cancer metabolism and to nominate new therapeutic targets from reprogrammed pathways.Keywords
This publication has 104 references indexed in Scilit:
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cellsNature, 2013
- Analysis of Tumor Metabolism Reveals Mitochondrial Glucose Oxidation in Genetically Diverse Human Glioblastomas in the Mouse Brain In VivoCell Metabolism, 2012
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose MetabolismCell, 2012
- Metabolism of [U‐13C]glucose in human brain tumors in vivoNMR in Biomedicine, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012
- Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopyJournal of Neuro-Oncology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Analytical strategies for LC–MS-based targeted metabolomicsJournal of Chromatography B, 2008